Skip to content

Clinical trials

Observational Gram-Positive Bacterial Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gram-Positive Bacterial Infections Phase: Observational Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20082
20141
20162
20171
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wyeth is now a wholly owned subsidiary of Pfizer2
Infectopharm Arzneimittel GmbH1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Melinta Therapeutics, Inc.1
NICHD Neonatal Research Network1
Odense University Hospital1
Pfizer1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai Pulmonary Hospital, Shanghai, China1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gram-Positive Bacterial Infections12
Bacterial Infections6
Gram-Negative Bacterial Infections3
Bacteremia2
Sepsis2
Soft Tissue Infections2
Staphylococcal Infections2
Bone Diseases, Infectious1
Brain Abscess1
Central Nervous System Bacterial Infections1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.